During last couple of decades, there has been an increase in chronic conditions and lifestyle diseases. This had led to an increase in demand for healthcare.  Heart disease, diabetes and musculoskeletal diseases require long term care and attention. In the past few years, diseases that need surgery are being closely looked at so that they can be noninvasive and post-surgical care can be made better resulting in less complications and recovery time. As stays at hospitals are time and resource consuming, a reduced stay ensures care to more patients and quicker recovery for the ones at home.

Health care industry is being hugely impacted by medical technology which improves diagnosis, ensuring effective and timely monitoring those results in reduced hospitalizations and better care. Home monitoring has made patient recovery extremely comfortable in their own homes without compromising their health. In the healthcare industry diagnostic imaging systems are important as they are extensively made use of in clinical purposes. Medical imaging or diagnostic imaging is a technique made use of to take images of body or body parts to ensure that doctors can make a correct diagnosis. The healthcare industry has been revolutionized by the medical imaging technology. The New England Journal of Medicine Medical says that in the last 1,000 years, imaging is an important medical advancement.

Medical imaging is popular in developed nations. Its use is increasing in developing markets of India, Brazil and China, which are predicted to be the fast growing markets. The reason is increase in government expenditure on modernization, healthcare and a growth in number of healthcare and hospital centers. Disease profiles keep on changing in these countries and more people are contracting lifestyle diseases hence there is increasing demand for better care.

CHAP 1. Executive Summary

CHAP 2. Emerging Diagnostic Imaging Technologies: Introduction

           2.1. Diagnostic Imaging
           2.2. Market Definition

CHAP 3. Market Overview

           3.1. Market definition
           3.2. Recent innovations and clinical trials
           3.3. Conventional versus emerging diagnostic imaging technologies
           3.4. Regulatory framework by geography
           3.5. Key buying criteria
           3.6. Top market analysis
           3.7. End user analysis
           3.8. Stakeholder analysis and supply chain management
           3.9. Key findings
           3.10. Strategic Recommendation

CHAP4. Drivers of Diagnostic Imaging Technologies

CHAP5. Restraints of Diagnostic Imaging Technologies

CHAP6. Opportunities of Diagnostic Imaging Technologies

CHAP7. Challenges of Diagnostic Imaging Technologies

CHAP8. Segmentation

            8.1. Radiography
           8.2. MRI
           8.3. Nuclear Medicine
           8.4. Ultrasound
           8.5. Elastography
           8.6. Tactile imaging
           8.7. Photoacoustic imaging
           8.8. Thermography
           8.9. Tomography
           8.10. Echocardiography
           8.11. Functional near-infrared spectrography
           8.12. Other emerging technologies

CHAP 9. Competitive Landscape

           9.1. Key Service Provider
           9.2. Key Strategies
           9.3. Market Growth and Shares
           9.4. Market Forecast

CHAP10. Geography Analysis

           10.1. North America
           10.1.1. U.S.
           10.1.2. Canada
           10.2. Europe
           10.2.1. UK
           10.2.2. France
           10.2.3. Germany
           10.2.4. Italy
           10.2.5. RoE
           10.3. APAC
           10.3.1. India
           10.3.2. Japan
           10.3.3. Korea
           10.3.4. China
           10.3.5. RoAPAC
           10.4. ROW

CHAP11. Company Profiling

            1.  Lumenis Ltd.
            2. Biolase
            3. Photomedex
            4. IRIDEX corporation
            5. Spectranetics Corporation
            6. Myriad RBM
            7. Pacific Biomarkers
            8. Universal Biosensors
            9. Novartis Diagnostics
            10. Target Discovery
            11. Roche
            12. Abbot
            13. Johnson and Johnson
            14. Bio-Rad Laboratories Inc.
            15. Siemens healthcare,
            16. Bracco Imaging S.P.A.,
            17. Covidien, Plc
            18. GE Healthcare
            19. Cardinal Health
            20. Fujifilm Holdings Corporation
            21. Cardinal Health Inc.
            22. BARCO
            23. NTP Radioisotopes (PTY), Ltd.\
            24. Bayer Schering Pharma AG
            25. Nanospectra Biosciences, Inc.
            26. Perkinelmer, Inc.
            27. Xemed LLC

LIST OF TABLES:

Table1.  Global emerging diagnostic imaging market by region, 2013-2020 (in $billion)
Table2.  Global Radiography market by region, in $million (2013-2020)
Table3.  Global MRI market by region, in $million (2013-2020)
Table4.  Global Nuclear medicine market by region, in $million (2013-2020)
Table5.  Global Ultrasound Market by region, in $million (2013-2020)
Table6.  Global Tactile imaging Market by region, in $million (2013-2020)
Table7.  Global Photo acoustic imaging Market by region in $million (2013-2020)
Table8.  Global Tomography Market by segments, in $million (2013-2020)
Table9.  Global Echocardiography market by region, 2013-2020 (in $million)
Table10.  Global other emerging technologies market by region, 2013-2020 (in $million)
Table11.   North America infertility treatment market, 2013-2020 (in $million)
Table12.   Asia-Pacific infertility treatment market, 2013-2020 (in $million)
Table13.   Europe infertility treatment market, 2013-2020 (in $million)
Table14.   Rest of the world infertility treatment market, 2013-2020 (in $million)

LIST OF FIGURES:

Figure1:  VALUE CHAIN ANALYSIS
Figure2:  Global emerging diagnostic imaging Markets share (%) in 2013
Figure3:  Key buying criteria for emerging diagnostic imaging
Figure4:  US in emerging diagnostic imaging market, 2013-2020 (in $million
Figure5:  Canada emerging diagnostic imaging market, 2013-2020 (in $million)
Figure6:  China emerging diagnostic imaging market, 2013-2020 (in $million)
Figure7:  India emerging diagnostic imaging market, 2013-2020 ($million)
Figure8:  Japan emerging diagnostic imaging market, 2013-2020 ($million)
Figure9:  South Korea emerging diagnostic imaging market, 2013-2020 (in $million)
Figure10:  RoAPAC emerging diagnostic imaging market, 2013-2020 (in $million
Figure11:  France emerging diagnostic imaging market, 2013-2020 (in $million)
Figure12:  Germany emerging diagnostic imaging market, 2013-2020 (in $million)
Figure13:  UK emerging diagnostic imaging market, 2013-2020 (in $million)
Figure14:  Rest of Europe emerging diagnostic imaging market, 2013-2020 (in $million)
Figure15:  Rest of the world emerging diagnostic imaging market, 2013-2020 (in $million)

Request for Sample/Customisation